JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB141462

SR1001, RORalpha and RORgammat inverse agonist

Be the first to review this product! Submit a review

|

(1 Publication)

MW 477.4 Da, Purity >98%. Potent, selective RORα and RORγt inverse agonist (Ki values are 172 and 111 nM for RORα and RORγ respectively). Suppresses IL-17 promoter driven transcriptional activity. Inhibits TRAP220 nuclear receptor box 2 peptide interaction (IC50 = 117 nM). Shows immunosuppressant effects in vivo..

View Alternative Names

IMD42, MGC129539, NR1F1, NR1F3, Nuclear receptor ROR-alpha, Nuclear receptor ROR-gamma, Nuclear receptor RZR-alpha, Nuclear receptor RZR-gamma, Nuclear receptor subfamily 1 group F member 1, Nuclear receptor subfamily 1 group F member 3, RAR related orphan nuclear receptor variant 2, RAR related orphan receptor C, isoform a, RAR related orphan receptor alpha, RAR related orphan receptor gamma, RAR-related orphan receptor A, RAR-related orphan receptor C, RORA_HUMAN, RORG_HUMAN, RZR GAMMA, RZR-ALPHA, RZRA, RZRG, Retinoic acid binding receptor gamma, Retinoid-related orphan receptor-alpha, Retinoid-related orphan receptor-gamma, Rorc, TOR, Transcription factor RZR alpha, fhl2a

1 Images
Chemical Structure - SR1001, RORalpha and RORgammat inverse agonist (AB141462)
  • Chemical Structure

Lab

Chemical Structure - SR1001, RORalpha and RORgammat inverse agonist (AB141462)

2D chemical structure image of ab141462, SR1001, RORalpha and RORgammat inverse agonist

Key facts

CAS number

1335106-03-0

Purity

>98%

Form

Solid

form

Molecular weight

477.4 Da

Molecular formula

C<sub>1</sub><sub>5</sub>H<sub>1</sub><sub>3</sub>F<sub>6</sub>N<sub>3</sub>O<sub>4</sub>S<sub>2</sub>

PubChem

44241473

Nature

Synthetic

Solubility

Soluble in DMSO to 10 mM

Biochemical name

N-[5-[[4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)phenyl]sulfamoyl]-4-methyl-1,3-thiazol-2-yl]acetamide

Biological description

Potent, selective RORα and RORγt inverse agonist (Ki values are 172 and 111 nM for RORα and RORγ respectively). Suppresses IL-17 promoter driven transcriptional activity. Inhibits TRAP220 nuclear receptor box 2 peptide interaction (IC50 = 117 nM). Shows immunosuppressant effects in vivo.

Canonical smiles

CC1=C(SC(=N1)NC(=O)C)S(=O)(=O)NC2=CC=C(C=C2)C(C(F)(F)F)(C(F)(F)F)O

InChi

InChI=1S/C15H13F6N3O4S2/c1-7-11(29-12(22-7)23-8(2)25)30(27,28)24-10-5-3-9(4-6-10)13(26,14(16,17)18)15(19,20)21/h3-6,24,26H,1-2H3,(H,22,23,25)

InChiKey

OZBSSKGBKHOLGA-UHFFFAOYSA-N

IUPAC Name

N-[5-[[4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)phenyl]sulfamoyl]-4-methyl-1,3-thiazol-2-yl]acetamide

Product details

This product is manufactured by BioVision, an Abcam company and was previously called 1902 SR1001. 1902-25 is the same size as the 25 mg size of ab141462.

Properties and storage information

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate long-term storage conditions
-20°C
Storage information
Store under desiccating conditions|The product can be stored for up to 12 months

Product protocols

Publications (1)

Recent publications for all applications. Explore the full list and refine your search

Heliyon 9:e20118 PubMed37809525

2023

Fasudil and SR1001 synergistically protect against sepsis-associated pancreatic injury by inhibiting RhoA/ROCK pathway and Th17/IL-17 response.

Applications

Unspecified application

Species

Unspecified reactive species

Pingping Liu,Zhenghui Xiao,Xiulan Lu,Xinping Zhang,Jiaotian Huang,Cheng Li
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com